Centrale del Latte d'Italia S.p.A. (BIT:CLI)

Market Cap	43.40M
Revenue (ttm)	345.81M
Net Income (ttm)	4.77M
Shares Out	14.00M
EPS (ttm)	0.35
PE Ratio	8.92
Forward PE	7.03
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	5,935
Open	3.100
Previous Close	3.100
Day's Range	3.100 - 3.100
52-Week Range	2.540 - 3.320
Beta	0.28
RSI	59.99
Earnings Date	Sep 12, 2025

About Ligand Pharmaceuticals

Centrale del Latte d'Italia S.p.A. engages in the production, treatment, processing, and sale of milk, dairy, and food products in Italy, Germany, and internationally. The company operates through Milk Products, Dairy Products, and Other Activities segments. It offers fresh and shelf-stable milk, and yogurt; vegetable drinks; desserts; milk-based training drink. The company offers its products under the TappoRosso, Polenghi, Mukki, Latte Tigullio, Vicenza, Giglio, Matese, Centrale del Latte Salerno, Optimus, Torre in Pietra, Ala, Polenghi, and ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1950
• Employees: 612
• Stock Exchange: Borsa Italiana
• Ticker Symbol: CLI

Financial Performance

In 2024, BIT:CLI's revenue was 349.71 million, an increase of 4.74% compared to the previous year's 333.89 million. Earnings were 4.42 million, an increase of 49.36%.